Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Matthew J Frigault, Jorg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T Jordan, Deborah Forst, Scott R Plotkin, Daniella Cook, Keagan S Casey, Kevin A Lindell, Gabriel D Depinho, Katelin Katsis, Eva Lynn Elder, Mark B Leick, Bryan Choi, Nora Horick, Frederic Preffer, Meredith Saylor, Steven McAfee, Paul V O'Donnell, Thomas R Spitzer, Bimalangshu Dey, Zachariah DeFilipp, Areej El-Jawahri, Tracy T Batchelor, Marcela V Maus, Yi-Bin Chen
Blood 2022;139(15):2306-2315